Nawab Qizilbash will speak and show a selection of practical examples and case studies under the title “Trials with observational designs”
OXON will present a review and discuss lessons learned from risk minimisation evaluation studies at the EFPIA PV Expert Group
We would like to thank you for visiting our booth at ISPE 2017 ANNUAL MEETING that was held in the Palais de Congress de Montreal from August 26 to August 30.
OXON will be presenting at the 20th Annual European Congress of ISPOR:
two poster presentations focused on Clinical Outcomes Studies
Head of OXON, Dr Nawab Qizilbash will participate
in EMA/DIA Information Day on
Measuring the Impact on Pharmacovigilance Activities.
OXON will be presenting at the 33rd International Conference for Pharmacoepidemiology:
Two oral and five poster presentations
OXON will be attending the ISPE Mid-Year Meeting with the theme “Ensuring Opportunities Become Reality”, held on April 1 – 4, 2017 at The Royal College of Physicians, London, United Kingdom.
OXON will be attending the ISPE Mid-Year Meeting with the theme “Ensuring Opportunities Become Reality”, held on April 1 – 4, 2017 at The Royal College of Physicians, London, United Kingdom.
22nd – 23rd February 2017, Pestana Chelsea Bridge Hotel, London UK
Nawab Qizilbash, Head of OXON, will be presenting “Post marketing drug surveillance”
The European Medicines Agency (EMA) has published the list of participants and the presentations of the different speakers of the workshop “Measuring the impact of pharmacovigilance activities”
